Previous studies performed in pancreatic and hematological cancers have also revealed increased MARCKS expression and MARCKS phosphorylation in cancer cells that have developed resistance to drugs such as oxaliplatin and proteasome inhibitors [57,58,59,60]. Here, MARCKS is linked to cancer.